University of California, Los Angeles
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Los Angeles sits in the top decile of US sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count).
University of California, Los Angeles: 897 sponsored US clinical trials, 158 recruiting.
University of California, Los Angeles sponsors 897 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 622 completed. 98 of these trials are in Phase 3-4 (later-stage) and 194 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of California, Los Angeles ranks in the top decile of sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
622 of 679 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
897 total, page 17 of 18
A Multicenter Study of NAP (AL-108) in Schizophrenia
NCT00505765
Treatment Study for Cognitive Deficits in Schizophrenia
NCT00505076
Randomized Crossover Study of Magnesium Supplementation
NCT00737815
Effects of Naturally Silicon-Rich Water on Bone Metabolism in Women
NCT01067508
Walking Study for Stroke Rehabilitation
NCT00428480
Study of Tibial Shaft Fractures in Children
NCT01238523
Early Family-Focused Treatment for Youth at Risk for Bipolar Disorder
NCT00943085
Modafinil vs Placebo for the Treatment of Methamphetamine Dependence
NCT00469508
A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
NCT00451204
Impulsivity in Pathological Gambling
NCT00580567
Central Venous Saturation (ScvO2) Monitoring in Pediatric Patients Undergoing Cardiac Surgery
NCT00883922
A Study Comparing Shunt Placement Versus Endoscopic Third Ventriculostomy in the Treatment of Hydrocephalus
NCT01115270
Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device)
NCT01546766
Cytokine-Associated Depression and Social Pain
NCT00949845
Evaluating a Low-Literacy Discharge Medication Education Tool
NCT00408733
Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder
NCT00429273
Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally
NCT00408538
Anorectal Microbicide Project(AMP): Rectal Health, Behaviors and Microbicide Acceptability
NCT00377221
Increasing Hepatitis B Screening Among Korean Church Attendees
NCT00760721
Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease
NCT00670709
Optimizing Outcomes Using Suboxone for Opiate Dependence
NCT00591617
Effectiveness of Family-Focused Treatment Plus Pharmacotherapy for Bipolar Disorder in Adolescents
NCT00332098
Repetitive Magnetic Transcranial Stimulation (rTMS) in the Treatment of Generalized Anxiety Disorder (GAD)
NCT00662584
Locomotor Training in Persons With Multiple Sclerosis
NCT00607126
Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices
NCT01079416
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
NCT00329706
Characteristics of Episodic Ataxia Syndrome
NCT00266760
A Study of Meditation as a Treatment for Epilepsy
NCT00370929
Starting Treatment With Agonist Replacement Therapies (START)
NCT00315341
Four Models of Telephone Support for Stimulant Recovery
NCT00744068
Behavioral Treatment of Insomnia in Aging
NCT00280020
Effects of Thymectomy During Cardiothoracic Surgery
NCT00263120
Effectiveness of a Family-Based Intervention for Adolescent Suicide Attempters (The SAFETY Study)
NCT00692302
Alcohol Use Reduction in Methadone Individuals With Hepatitis C Virus(HCV)
NCT00958763
Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia
NCT00330551
Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia
NCT00333177
Prometa Pharmacotherapy for Methamphetamine Dependence
NCT00260481
Integrated Behavioral Therapy for Treating Children With Selective Mutism
NCT00458198
Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia
NCT00423943
Family to Family: Psychoeducation to Improve Children's Outcomes in HIV+ Families
NCT01037946
Amyloid Plaque and Tangle Imaging in Aging and Dementia
NCT00355498
Statin Therapy in Heart Failure: Potential Mechanisms of Benefit
NCT00233480
Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression
NCT00200902
Enhancing Recovery After Cardiac Surgery
NCT00522717
Well-Child Care Redesign: A New Model of Care for Children in Low-Income Families
NCT02262962
Gender-Responsive Treatment for Women Offenders - 1
NCT00249613
Mindfulness Meditation Training in HIV
NCT00600561
Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder
NCT00674219
Project SHARE (Senior Health and Alcohol Risk Education)
NCT00107640
Use of Risperidone in ECT for Treatment Resistant Depression
NCT00203723
What is open in the University of California, Los Angeles pipeline
158 recruiting of 897 indexed (18% open); 622 completed (69%).
Phase mix: 98 late (III/IV) vs 194 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Los Angeles: open-pipeline peers nationwide
Peers matched on 897 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 897 trials (± recruiting share)
- Indiana University · 890 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- ConvaTec · 18% recruiting · 17 trials
- Endologix · 18% recruiting · 17 trials
- National Institute on Deafness and Other Communication Disorders (NIDCD) · 18% recruiting · 34 trials
- NICHD Pelvic Floor Disorders Network · 18% recruiting · 17 trials
Related
What to do with this University of California, Los Angeles page
897 registered trials is a research-attention snapshot, not an endorsement of University of California, Los Angeles or any single study.
- 158 of University of California, Los Angeles's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of California, Los Angeles studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Los Angeles pipeline card: 897 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.